Amongst the speakers were Catherine Oxtoby MRCVS, Risk Manager at the Veterinary Defence Society, and Dr Huw Stacey, director of clinical services at Vets4Pets.
Dr Stacey explained how Vets4Pets and Companion Care practices are embracing a culture of sharing information when things don’t go according to plan in practice.
He said: "We all face challenges in the workplace, and this event focused on how different professions can share ideas and good practice and how they find solutions to any challenges.
"The culture of aviation and maritime is one of minimising risk and putting safety first, and it is fascinating to compare their approach to that found in medicine and veterinary.
"One common theme we discussed was the wellbeing of both professionals and patients or clients, with tiredness being at the top of the list of things that can negatively affect wellbeing and performance.
"Both aviation and maritime recognised that long shifts, particularly overnight, needed to be reduced in order to improve the outcome for everyone.
"In veterinary and human medicine, tiredness and long shifts are often worn as a badge of honour and being tired at work was something that should be admired, rather than addressed.
"But, tired vets are effectively neglecting themselves and their own wellbeing, which in turn leads to pets not receiving the best level of care in practice.
"This is something we’re taking seriously at Vets4Pets and Companion Care, and we’re currently looking at ways to decrease the risk of overworked and tired vets and vet nurses."
Another area of discussion was around the reporting of near misses and when things don’t go right, and how veterinary professionals need to identify and share the learnings from these events, not only within their practice, but with the wider profession too.
He said: "We need to continually emphasise the concept of a ‘just’ culture, to ensure our colleagues feel confident about reporting incidents open and honestly."
"It is not in the interests of the professional, the patient or the client to bottle things up, and at Vets4Pets and Companion Care we’re encouraging all of our practices to adopt the VDS VetSafe system, which provides a mechanism for sharing incident reports across the profession, enabling us all to learn from them to the benefit of our patients."
The allied professionals that the BVA says should be led by veterinary surgeons include: Registered Veterinary Nurses (RVNs), Official Auxiliaries/ Meat Hygiene Inspectors, embryo transfer technicians, equine dental technicians, foot trimmers, farriers, hydrotherapists, animal behaviourists and veterinary physiotherapists.
To clarify where the responsibility for a patient sits and how it is shared between veterinary surgeons and allied professionals, the new policy statement also calls for:
The regulation of allied professionals to include mandatory veterinary diagnosis and oversight and appropriate access to veterinary records as pre-requisites before treatment;
Clarity on the delegation of duties for RVNs under Schedule 3 of the Veterinary Surgeons Act and protection of the ‘veterinary nurse’ title in legislation;
Consultation with the veterinary profession on any regulatory changes that may arise as a result of technological or other innovation.
British Veterinary Association President Simon Doherty (pictured right) said: "Against an evolving landscape, it’s essential that the veterinary profession keeps pace with change and addresses the challenges and opportunities it presents.
"Vets across sectors have always worked closely with allied professionals. The hub and spoke model acknowledges and clarifies this working relationship with clear lines of accountability and responsibility for the animals under our care. It also emphasises that vets’ right to diagnose, prescribe, and undertake surgical procedures and medical treatments must not be undermined.
"An effective and efficient vet-led team can help deliver better animal health and welfare, improved client care, and more effective use of skills within the veterinary professions. Given the ongoing workforce shortages, a strengthened veterinary workforce also has the potential to ease recruitment and retention concerns for both vets and RVNs and offer improved wellbeing.
"BVA will continue working with professional bodies and organisations to formalise the hub and spoke model, promote the value of regulation, and drive up professional standards."
Baycox Iron Injection is indicated for the concurrent prevention of clinical signs of coccidiosis (such as diarrhoea) in neonatal piglets on farms with a confirmed history of coccidiosis caused by Cystoisospora suis, and the prevention of iron deficiency anaemia.
Professor Nicole Kemper, Director of the Institute for Animal Hygiene, Animal Welfare and Farm Animal Behaviour at the University of Veterinary Medicine Hannover in Germany said: "Piglets go through intense handling in their first days of life. While this is done to give them a better start to life and protect them from disease, it can also cause a lot of stress. Measures to reduce the need for piglet handling can make an important contribution to enhancing piglet well-being in the farrowing pen."
Octavio Orlovsky Eckhardt, Head of Species Marketing Swine at Animal Health, Bayer said: "A combination therapy that can effectively address these concerns with reduced handling can make a real difference for pig health and well-being.
"At the same time, farmers and workers can benefit from the reduced labour. For example, on a 1,000 sow farm, the reduced complexity is estimated to save up to one full work day every month."
For more information on Baycox Iron Injection, contact your local Bayer Animal Health representative.
Survey forms are available from Boehringer Ingelheim Territory Managers or the survey can be completed online at https://bovikalc.typeform.com/to/jVGllV.
There will be a prize draw amongst the completed entries for 20 Bovikalc metal applicators, outers or gilets.
The survey will try and assess the scale of the hypocalcaemia problem on dairy and beef farms as well as look at the impact it has on the farm and productivity.
Boehringer says milk fever is currently thought to affect between 4-9% of the UK’s dairy cows, with the subclinical form affecting up to 39%.1,2
The survey will provide another up-to-date figure to compare with existing data and look at any regional trends that might exist.
Farmers are being encouraged to complete the survey regardless of whether they believe milk fever is an issue on their farm or not.
Bovikalc Brand Manager, Mathieu Maignan said: "We are really keen to find out about the real-life experience of milk fever and what really matters to farmers so that we can use this knowledge to improve the approach to managing the condition."
Kath Aplin, Veterinary Adviser at Boehringer Ingelheim (pictured right), is hoping to find out more about the recognition of the signs of subclinical milk fever in particular. She said: "Milk fever is not always well recognised by farmers as a predisposing factor in a number of conditions associated around transition, in particular. It will be really interesting to see if they feel there is a connection between those conditions and low calcium levels and how this affects which animals they target with calcium supplementation and other interventions."
The survey will run until 31st August 2019. The results will be shared with the farming and veterinary community alongside any insights gained into ways to improve the approach to milk fever.
References
1243 farmers took part in the survey, which was held in partnership with the National Beef Association, British Dairying magazine, the relevant farming unions and the four eradication programmes.
Matt Yarnall from Boehringer said: "Reliance on veterinary input for this decision shows how valuable client discussion and guidance is. And further interrogation of the data shows other areas of BVD control where veterinary input could be extremely valuable.
"Too many producers are still holding onto PI animals in the hope they can be reared successfully and too many are making basic mistakes when it comes to herd biosecurity.
"The survey data revealed that 43% of farmers in Wales have identified a PI, but it is hugely concerning that almost half (42%) of these producers would not cull them immediately; these animals will go on to spread virus throughout the herd."
In Northern Ireland, 26 individual producers said they have kept a PI. "However, 20 had to be put down before reaching adulthood or had to be treated for other health conditions," said Matt. "Even in Scotland, with its well-established scheme, a small percentage of farmers claim they would isolate a PI and try to rear to slaughter and it was exactly the same in England."
Similarly, when it came down to the definition of a closed herd, Boehringer reports that there was significant lack of understanding about what this actually means.
Matt said: "Of the 62% of English producers that state they are closed herds, 2% rear calves away, 19% bring bulls in, 2% buy in heifers or cows and 1% purchase fattening stock.
"Obviously, this means they are not truly a closed herd and supports previous years when 23% and 24% of ‘closed herd’ producers in 2018 and 2017 respectively also brought bulls onto the farm.
"Add to this that 10% of these herds do not currently vaccinate so will not be protected against the BVD virus, and it is clear to see how vulnerable they are."
In Wales, 56% of herds were classified as closed, yet 12% still brought bulls on to the farm. Likewise in Northern Ireland, 60% of farms classified their herds as closed but 20% brought bulls on to the unit. The vast majority of Scottish herds also claimed to be closed, yet there were still inconsistencies around buying policy and biosecurity.
Matt said: "A certain lack of awareness about both the BVD Stamp it Out initiative and Gwaredu BVD schemes (43% English and 27% of Welsh producers respectively claimed to have no knowledge of these programmes) could actually be a positive for vets. It could be the perfect opportunity to engage in proactive conversations with clients, covering issues such as testing, PI removal and biosecurity."
This only affects batch number C967336A, expires before 07/2020. Any other batches of Tylan 200 Injection are not affected and may continue to be distributed.
Elanco is contacting wholesale dealers and veterinary surgeons to examine inventory immediately and quarantine products subject to this recall.
For further information regarding the recall, please contact Ms Victoria Haslingden 01256 779519 or email elanco_orders@lilly.com
Tialin is licensed for the treatment of dysentery, colitis, ileitis, pneumonia and pleuropneumonia in pigs. It is also suitable for the treatment and metaphylaxis of chronic respiratory disease and infectious synovitis in chickens and infectious sinusitis and airsacculitis in turkeys. Withdrawal times range from zero in eggs to two - six days in meat and offal.
The product is available in two strengths: 25% (250 mg/ml) and 12.5% (125 mg/ml). It can be bought in five and one litre bottles with a shelf life of two years or three months once opened.
Dechra Brand Manager Emma Jennings said: "Any of these diseases could have a widespread effect on a herd or flock of any size so it is vital that veterinary professionals have access to a treatment such as Tialin to offer farmers.
"Its short withdrawal times and long shelf life makes it a cost effective and valuable tool for vets and farmers in their treatments of these diseases. All the products in our premium SoluStab range have been specifically developed with a unique formula to provide the optimum balance of stability and solubility."
For more information, visit www.dechra.co.uk/therapy-areas/food-producing-animal/water-medication.
Dechra also offers an online tool to calculate dosage for SoluStab products at http://calculator.solustab.eu/.
The company says Taurador Pour-on provides a stress-free, easy to use treatment, with persistent activity against a large number of cattle parasites, therefore ensuring effective coverage over long periods of the grazing season.
Matthew Swanborough BVSc MRCVS, Veterinary Advisor for Norbrook, said: "The farming industry will be aware that heavy worm burdens can significantly affect the health and productivity of cattle, potentially as much as £100 per head of cattle. We cannot simply ignore these parasites but we must tackle them responsibly. A comprehensive worming strategy is a vital component of any animal health plan, which should be composed of management strategies and any necessary anthelmintic treatments."
Norbrook highlights the product's efficacy against the gutworms Osterstagia osterstagi, Cooperia oncophora and lungworm, Dictyocaulus viviparous, with persistent action against these parasites for 35 days, 28 days and 42 days respectively.
Doramectin, the active ingredient in Taurador, is an anthelmintic belonging to the macrocyclic lactones (3-ML) group, along with ivermectins. Norbrook says both compounds share a wide spectrum of antiparasitic activity and produce a similar paralysis in nematodes and parasitic arthropods.
Dr Leigh Sullivan, Norbrook Large Animal Product Manager, said: "Taurador is the company’s thirteenth new product introduction in the last four years and it is a significant addition to our portfolio. Internal parasites such as gutworms and lungworm can have a serious impact on animal health and welfare, as well as financial implications for farmers, so it is great to be able to provide another product to help reduce the economic impact of these parasites."
Taurador is available in three different pack sizes (1L; 2.5L and 5L) and an appropriate dosing applicator is also available.
The test, which enables the rapid identification of cattle infected with Mycobacteria, was first developed by Dr Swift as part of his PhD studies at the University of Nottingham. Since joining the RVC, he has continued to evolve the technology working alongside academics at his former university.
Dr Swift and Dr Rees were presented with the award by HRH the Princess Royal.
The Royal Dairy Innovation Award recognises research and development in the field of dairy farming and is awarded for the most practical, relevant product or service which is, or likely to be the most significant innovation for the future.
The RVC says the test is able to detect mycobacteria in the blood and milk of cattle within six hours using a bacteriophage-based technique. As a result, cattle affected by Mycobacterium bovis, the bacteria that causes bovine TB, can be diagnosed for the disease more quickly, allowing for more effective disease management in herds.
Additionally, the test has been used to effectively detect Johne’s Disease – another endemic illness that affects dairy cattle – in new born calves for the first time. By being able to catch the disease at an early stage, this test can help further with controlling infections in dairy herds.
The test is now licenced to spin-out company, PBD Biotech Ltd and marketed as Actiphage. It can also be used as a highly sensitive quality assurance test in milk and dairy products.
Dr Swift, who is a Research Fellow in antimicrobial resistance, said: "It is really exciting to be recognised with this award. Translating technology from the bench to be used in real-world scenarios is a great thing and really shows the impact of our research. Hopefully this will help manage two extremely difficult diseases in the UK and worldwide."
Photo: Benjamin Swift (RVC), Dr Cath Rees (University of Nottingham), Princess Anne and Dr Berwyn Clarke (PBD Biotech).
Till then, veterinary surgeons are advised to make due diligent attempts to source a UK-authorised product before considering importing an alternative medicine.
Procaine hydrochloride is used in farm animal medicine in particular, to provide local and regional anaesthesia for a range of procedures including calving, lambing, caesarean operations, castration and dehorning of cattle, with demand particularly high in the spring.
Simon Doherty, BVA President, said: "We’re pleased that VMD has issued some clarification to answer our concerns over procaine hydrochloride shortages. BVA had heard from some veterinary practices that they were only able to get hold of a fraction of what they needed, which would have resulted in a very acute impact on farm animal welfare. Although we had moved to get assurances sooner, we appreciate that there are formal routes for reporting and that the announcement of any shortage must be handled sensitively to avoid exacerbating the problem.
"VMD’s clarification is especially timely as this is a period of peak seasonal demand for these products. We will keep our members closely informed of any further developments."
Revozyn RTU, which contains 400 mg/ml Penethamate hydriodide, is the first ready-to-use injectable narrow spectrum Penethamate on the UK market. It can also be used to treat relapses of old infections.
Dechra says that the intramuscular injection works by diffusing through the blood vessels and accumulating in the udder tissue and milk, treating the whole udder effectively. Apparently the new formulation also features an ion trapping mechanism that results in high Benzylpenicillin concentration in milk and udder tissue.
Revozyn RTU comes in a 50ml multi dose vial. It has a 28-day shelf life after first use and has withdrawal periods of four days for milk and 10 days for meat and offal.
Dechra Brand Manager Emma Jennings said: "The treatment and control of mastitis is one of the largest costs to any dairy farmer. It affects productivity and cow welfare and we are delighted to be able to introduce this revolutionary product.
"Revozyn RTU can change the way that clinical and subclinical mastitis in dairy cattle is treated. Its narrow spectrum of activity means that the risk of antibiotic resistance is reduced and there is no need for additional animal handling, thereby saving time and protecting user safety.
“The flexible dosing of Revozyn RTU and 28-day shelf life also make it a cost effective option for farmers".
For more information, visit www.dechra.co.uk.
The new website explains what Veterinary Specialists are, how they may be able to help, and how the referral process works. The BCVSp says it has been designed to be a useful resource which primary practices can direct their clients to if a referral is being considered.
As well as being able to search for a Specialist by location and by discipline, owners can also read some real life patient case studies following the referral, treatment journeys and outcomes of animals that have benefited from Specialist care and meet some of the Specialists via podcast links.
BCVSp Trustee Celia Marr said: "While most happy healthy animals will never need Specialist veterinary care, if they do we want their owners to know that we are here to help.
"There are many hundreds of Specialists working at the forefront of veterinary care and also those working in research, pathology and academia, helping to advance animal health and welfare, every day. We believe our new website should help to spread the word and make referral more understandable and accessible."
Visit the new website at www.yourvetspecialist.org
Forte highlights that Utertab's intrauterine administration allows it to act directly in the target tissue. It is presented in a perforated blister pack for better sealing.
Dr John Henderson, Large Animal Product Manager at Forte Healthcare Ltd said: "Given the need to use appropriate first-line antibacterial drugs where possible we are delighted to bring vets a new Tetracycline pessary, ‘Utertab’, for the treatment of metritis and retained foetal membranes.
"In-situ therapy for these conditions has more recently been neglected in favour of injectables but still has much to recommend it. We look forward to highlighting these benefits over the next few months."
For further information on Utertab 2000mg, contact your local Forte Territory Manager or enquiries@fortehealthcare.com.
The new vaccine offers up to 12 months' immunity against three of the biggest diseases that cause reproductive failures in pigs.
Alexandre Carvalho, business unit manager for pigs at MSD Animal Health, says the vaccine has the broadest protection against Leptospira on the market, offering protection against nine different serogroups including, Australis and Pomona.
He added: "This vaccine also includes protection against the Tarassov serogroup, which is unique to the product.
"It’s important to note that PORCILIS Ery+Parvo+Lepto can be used for mass vaccination and during pregnancy, which hasn’t been possible with previous products."
In its updated position statement, the association emphasises its support of current UK legislation and says it would like to see improved implementation of current laws, in particular when informed by an evidence-based welfare outcomes approach.
The BVA also recommends that any proposals to improve welfare during transport should embrace all forms of transport and include welfare issues before, during and after movement. This, it says, would help ensure that a well-defined set of animal welfare standards are met for the entirety of any journey.
The BVA recommends that animals are slaughtered as close to the point of production as possible and supports the exploration of further opportunities which would assist this. It recognises that transportation of live animals can be unavoidable in some situations – for example, journeys between the Scottish Islands and Highlands – but says that no animal should be exported to a destination with unknown welfare standards, to one using systems currently banned in the UK or to a country where it would be slaughtered without stunning.
BVA President Simon Doherty said: "Any kind of movement has the potential to impact on an animal’s health and welfare. Ideally, we’d like to see livestock slaughtered close to the point of production, as long as all legislative health and welfare standards can be maintained. However, we recognise the high standards of welfare in the UK and support better implementation of current legislation.
"We have taken care to reiterate that any improvements made to live animal transport should consider welfare issues before, during and after movement so that a more complete approach is taken on this issue.
"We recognise that journey length is not the only influencer of welfare conditions for animals, and transport needs to be looked at as a whole rather than focusing on single factors. The most important thing for Government to do is to consider the evidence base when it weighs up options for making improvements."
Henry Schein said in a statement on Friday that it had sold the business in order to focus on its dental and medical markets and pursue new investment opportunities.
Covetrus says it will be using the experience, technology and global scale of the merged companies to provide veterinary practices with a more comprehensive set of integrated services and technology solutions, and tools to strengthen client relationships and grow their practice.
Covetrus launched on Nasdaq last Friday, when President and Chief Executive Officer Benjamin Shaw, said: "Today marks an important new chapter in the world of veterinary medicine, as we launch Covetrus as a new company listed on Nasdaq.
"We look forward to strengthening our customer relationships and expanding our veterinary practice partnerships worldwide as we bring more comprehensive and powerful solutions to market to meet their evolving needs and improve health and financial outcomes."
The latest figures from 2017/18 reveal that over 120 million animals were slaughtered in England and Wales without being stunned first1.
In an open letter to Environment Secretary Michael Gove, the BVA and the RSPCA urge the UK Government to change legislation in England which currently allows non-stun slaughter for religious purposes, and provide further public transparency on this issue by releasing the comprehensive 2018 slaughter survey results, which Mr Gove himself signalled would be published by Autumn 2018.
Until such legislation is in place the RSPCA and BVA are calling for:
meat to be labelled with the method of slaughter, e.g. stunned or non-stunned, so consumers are fully informed about the meat that they are buying.
non-stun slaughter to only be permitted at levels that meet local religious community demand for this type of meat in the interests of limiting animal pain and suffering.
a ban on export of meat from non-stunned animals or live animals destined for non-stun slaughter.
an immediate post-cut stun for cattle, sheep, goats and deer to reduce the period of pain and distress.
The letter follows a recent, high profile decision to ban the slaughter of animals without prior stunning in the Flanders region of Belgium which came into force at the start of the year. Belgium joins several other European countries, including Iceland, Sweden, Switzerland and Denmark in making this decision, demonstrating that a full ban on non-stun slaughter is possible within EU law.
RSPCA chief executive, Chris Sherwood said: "Until there is a change in the law to end non-stun slaughter, there are several measures the UK Government could introduce to reduce the suffering involved in this practice. For example, by ensuring trade deals with other countries do not include non-stun meat or live animals for non-stun slaughter, clear labelling should be adopted to enable consumers to make an informed choice about the meat they buy and how it was slaughtered."
BVA President Simon Doherty said: "The UK Government has repeatedly stated it would prefer to see all animals stunned before slaughter but has taken no action to address this critical welfare issue that affects millions of animals every year. It is doubly disappointing that data that would have provided a valuable benchmark for levels of non-stun slaughter in the UK has yet to see the light of day despite assurances throughout last year that it would soon be made public.
"There is a huge groundswell of support for a ban on non-stun slaughter, and recent developments in Belgium show that decisive change is possible where public support is matched by political will. Michael Gove has made clear that he wants to maintain and build on the UK’s reputation as global leader on animal welfare; banning non-stun slaughter is a surefire way of showing he will deliver on this commitment.
"If slaughter without stunning continues to be permitted in the UK, then meat and fish from this source must be clearly labelled, to help customers make informed choices about the food that they buy and eat."
You can sign the open letter at: www.rspca.org.uk/endnonstun and join the online debate using the hashtag #EndNonStun.
The main changes announced today are:
In the future, the revalidation interval, which currently ranges from two to five years depending on the course, will be standardised at 4 years.
Currently, there is a two-month window in which Official Veterinarians (OV) can submit their final declarations, on completion of the course, if they want to set their next revalidation interval from the end of the window.
The revalidation window will be extended to a six-month period prior to the completion deadline date. If completed in this window, the date of the next revalidation would be taken from the deadline date and not the date of completion.
APHA is discussing ways of making invigilation more flexible, to help those working in sole-charge or remote practices. One option being investigated with course accreditation providers is remote invigilation, though this would come at extra cost.
All the multiple choice questions in the online exams are being reviewed to make sure they test the ability to perform the role, and in the future, candidates will be given more feedback at the end of the test (ie which questions they answered incorrectly).
In terms of CPD requirements, there will be clarification on what can be considered relevant CPD towards the 10 hours that need to be completed over the four-year timeframe.
Lastly, APHA has announced a raft of changes concerning course content, and that it will itself review all the courses to consider how the number of courses and topics can be rationalised, how to reduce the number of qualifications any OV might need and/or the time spent revalidating, and how to reduce the content without losing quality.
The BVA, which spearheaded the campaign for reform, has welcomed the announcement. Simon Doherty, BVA President, said: "We’re delighted that APHA has taken on board our members’ concerns with the current system and proposed improvements that should make the process much more fair and consistent while continuing to maintain high standards. This is a really crucial time for ensuring that the workforce retains skilled professionals and is at full strength to keep animal welfare standards high, protect public health and meet demand for export certification after Brexit.
"This piece of work is a shining example of what can be achieved when vets pull together to air concerns and make the case for change. We will continue to work closely with APHA to explore and put in place ways of making the revalidation process as fit for purpose as possible for this critical section of the workforce."
Full review: http://apha.defra.gov.uk/documents/ov/Briefing-Note-0519.pdf
Whilst you're here, take a moment to see our latest job opportunities for vets.
In its statement, the company blamed the situation on the poor performance of 24 practices it bought in the Netherlands, and its new farm and equine divisions.
CVS says that another important factor has been employment costs, in particular the increase in market rates for locum veterinary surgeons and nurses on which it remains heavily reliant.
The company also blames its financial performance on the poor support of pharmaceutical companies, which it says it is continuing to push for transparent and 'appropriate' pricing.
Aside from trying to drive down the costs of drugs, the company says it has introduced 'additional procedures' designed to reduce the cost of employing locums, although it didn't specify what these are.
The group is also reevaluating its pipeline of acquisitions, in particular the multiples it is prepared to pay.
At the time of writing, the CVS share price had dropped over 28% to 465p overnight and 70% since the share price peaked at 1477p in November 2017.
In the game of acquisitions musical chairs, did the music just stop?
Full trading statement.
Consequently, the company says the sheep sector is going to have to take a more proactive approach to parasite control if it is to achieve the best possible environmental standards.
The research by SRUC and the Moredun Research Institute showed parasite infections in lambs can lead to a 33% increase in methane output1 and that parasitism is one of the top three livestock diseases which increase greenhouse gas (GHG) emissions2 and is cost-effective to manage.
Eurion Thomas, European operations manager at Techion, says that despite current emissions from sheep being over-exaggerated, the sector will need to act if the NFU’s aspiration for net zero emissions from agriculture by 2040, is to be achieved.
Eurion said: "While targets to further reduce GHG emissions may appear to be burdensome, there are some simple steps farmers can take that’ll help minimise emissions while also improving business profitability. This includes incorporating regular faecal egg counts (FEC) into routine flock management to increase the accuracy of worm control.
"Worms reduce performance, in particular feed conversion ratio (FCR) meaning animals take longer to finish at lower weights. In addition, the research shows animals with worms release more methane per day due to the upset they cause to the digestive system.
"Better parasite control can therefore reduce number of days to finishing, improving production efficiency and lowering methane emissions per unit of meat produced. The number of days to slaughter and FCR are also correlated to profit margins, providing an opportunity to improve the bottom line."
Eurion says one of the reasons endemic diseases such as worm burdens are so detrimental to production efficiency and emissions is because often the disease has significantly impacted animal performance before it has been identified. Regular faecal egg counts (FEC) and an accurate treatment programme are therefore crucial.
Eurion said: "FECPAKG2 is the latest in image-based, internet-connected, FEC technology and means testing can be carried out virtually anywhere by anyone, including on-farm by the farmer.
"Because digital images of parasite eggs are produced, analysed and stored online, FECPAKG2 provides rapid results while offering greater quality control and auditability. This is encouraging more frequent testing and better decision making at farm level."
A collaborative research project between Sainsbury’s and Techion3 showed accurate treatment of the right animals, with the right wormer, at the right time, improved daily liveweight gains (DLWG) while reducing wormer use in sheep by up to 50%.
Eurion said: "Addressing the environmental impact of red meat production is arguably one of the biggest challenges the sector faces and introducing FEC is one simple way farmers can proactively work towards this, while improving business profitability."
To enter the competition, click here and list the BRD risk factors you can see.
The competition closes on 8th February 2019, when ten gilet winners will be picked at random from those entries that contain the most risk factors.
After the competition ends, you will also be able to download the cartoon for use in your practice and with your farming clients.
Andrea Tarr BPharm MSC MRPharmS, the founder and director of Veterinary Prescriber said: "Prescribing is a neglected aspect of veterinary practice. When it comes to making treatment decisions, vets are very poorly supported by their professional organisations, the pharmaceutical industry has a hugely distorting influence and there's a lack of access to really helpful information.
"We're determined to use the expertise in Veterinary Prescriber to change this, and support vets in their use of medicines in the best interests of animals, their owners and the environment.
"With this in mind, we start the year with a learning module of good veterinary dispensing practice."
The module explains what constitutes a well-run dispensary, including how to organise, handle and store medicines correctly. It reviews the legal classifications of medicines, including controlled drugs and the cascade. It also considers why dispensing errors occur and what to do when they happen.
Veterinary Prescriber says its modules are evidence-based, peer-reviewed and independent of the pharmaceutical industry.
Subscription costs £9.95 per month, which you can cancel any time. To subscribe, visit: www.veterinaryprescriber.org
A free copy of the compendium has been sent to every veterinary practice in the UK, and it is also available online at: www.noahcompendium.co.uk. A special edition of the book commissioned by AMTRA will also be available for its SQPs shortly.
NOAH chief executive Dawn Howard said: "The NOAH Compendium, in all its formats, remains a major part of NOAH’s efforts to ensure appropriate access and responsible use of medicines for all animals. We are pleased it is even more comprehensive this year, as we continue to expand its list of contributors.
"Every NOAH member, as well as the non-member participants in the NOAH Compendium, is a signatory to the NOAH Code of Practice on Promotion, which demonstrates their commitment to operate above and beyond any regulatory requirements."
She added: “As well as product datasheets, the Compendium includes another vital resource – the contact details for each participating company. Company veterinary and technical advisors have detailed knowledge about their company’s medicines. The NOAH Code includes the requirement for NCAH qualification for NOAH staff in technical dialogue with prescribers and users of animal medicines – meaning their advice can be regarded as a valuable and trusted resource. They are ready to talk to prescribers about the use of a medicine in a particular animal or in a particular situation, as well as to explain any queries about the data sheet."
Veterinary practices that have not yet received a copy, perhaps because they are new or have changed address in the past year should contact NOAH (noah@noah.co.uk).
Extra copies are also available to order, for £47.50. Special prices are also available for bulk orders.
The disease had been identified as a priority by the Wales Animal Health and Welfare Framework Group.
Further details will be announced in the coming months following ongoing discussions with industry representatives.
The Minister said: "Sheep scab has significant economic consequences for sheep producers and animal welfare issues for sheep. It is one of the most contagious disease of sheep in Wales and eradicating it is a priority for us and the industry.
"I’m pleased to be able to announce £5m Rural Development Programme funding will be used to help support the industry tackle the disease. Eradicating the disease has the potential to deliver significant lasting economic benefits for the sector at a particularly challenging time as we prepare to leave the European Union."
Miss Padron Vega faced four charges. The first and second alleged that in February 2016, for the purposes of an application to the Food Standards Agency for a Certificate of Competence under the Welfare of Animals at the Time of Killing Regulations 2015, she backdated two separate veterinary witness certificates to 7 December 2015. The third charge alleged that her acts of backdating were misleading, dishonest and in breach of the RCVS Principles of Certification.
The fourth charge against Miss Padron Vega was that, between September 2015 and February 2016, she failed to fulfil her duties as an Official Veterinarian in respect of: failing to prepare herself for the implementation of the Welfare of Animals at the Time of Killing Regulations 2015; failing to have regard to the information provided to her by her employers about the regulations and their implementation; failing to take any steps to ensure that the two individuals for whom she had given veterinary certification were licensed to perform slaughter in accordance with the regulations; and failing to identify that two individuals were not licensed to slaughter in accordance with the regulations.
The Committee heard that the Welfare at the Time of Killing Regulations were introduced on 5 November 2015 which placed the responsibility on slaughtering operations not to permit animal welfare abuses and required certification by a veterinary witness regarding compliance.
The new regulations required existing slaughter licence holders to apply for a Certificate of Competence before midnight on 8 December 2015 or they would not be permitted to continue operating even with experienced operatives.
During the hearing, Ms Padron Vega admitted charges 1 and 2, admitted that she had been in breach of the Principles of Certification and admitted the fourth charge against her.
However, she denied she had backdated the certificates in a misleading or dishonest way, maintaining that she had done so by mistake.
In considering the facts of the case, however, the Committee rejected this argument and, taking into account that she had been responsible for veterinary certifications in the UK since 2001, found that her conduct was knowingly misleading and dishonest.
The Committee then went on to consider whether the charges she admitted and the charges found against her constituted serious professional misconduct, both individually and cumulatively.
The Committee found that all the charges amounted to serious professional misconduct.
In relation to charge 4 in particular Stuart Drummond, chairing the Committee and speaking on its behalf, said: "The Committee has found that the respondent failed to read even those emails which her employer sent to her which were marked ‘urgent’ or ‘OV importance high’. She must have known that her employers were directing attention to some new statutory scheme for she was provided with PowerPoint slides in that regard which she could read at any time of her convenience. The Committee has been driven to the conclusion that the respondent did not even bother to read those slides for, had she done so, she would have known that she needed to apprise herself of the requirements of the impending new statutory scheme.
"The respondent’s failings in this regard are little short of extraordinary, especially given her obligations as Lead OV for FAI Farms. The total abdication of her responsibility to understand the requirements of the Regulations governing the slaughterhouse operations constitutes, in the judgement of this Committee disgraceful conduct in a professional respect."
The Committee then went on to consider the aggravating and mitigating factors in the case. In terms of aggravating features the Committee noted a lack of insight into the gravity of her conduct, that her conduct undermined in the most serious way public confidence in veterinary certification, and that there were animal welfare implications on her conduct as a number of chickens had to be removed from the slaughterhouse and alternative arrangements made because an auditor from the Food Standards Agency found that it was not compliant.
In mitigation the Committee considered that, despite the potential risk of harm, there was no actual harm occasioned to animals, that Miss Padron Vega has had a long and otherwise unblemished career and no previous issues with the RCVS and that she had admitted some of the charges against her.
Stuart Drummond added: "Ultimately, the Committee was driven to the conclusion that the public’s desire to see the implementation of the highest certification standards in relation to activities which impact on animal welfare and public health, and which did not occur on 3 February 2016, must outweigh this particular veterinary surgeon’s desire and need to continue in practice. This is not a conclusion which the Committee has arrived at lightly. On the contrary, it has reached this decision because it has been driven to the conclusion that it would be failing in its public duty to protect the wider public interest in the maintenance of standards of honesty and right conduct in a member of the profession.
"It is, therefore, the conclusion and decision of this Committee that the only proper sanction that can be imposed in this case is that the respondent’s name should be removed from the Register and it directs the Registrar accordingly."
Miss Padron Vega has 28 days from being informed of the Committee’s decision to lodge an appeal with the Privy Council.